44
IRUS TotalDownloads
Altmetric
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
File | Description | Size | Format | |
---|---|---|---|---|
bmj.m1985.full.pdf | Published version | 738.32 kB | Adobe PDF | View/Open |
Title: | Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study |
Authors: | Docherty, AB Harrison, EM Green, CA Hardwick, HE Pius, R Norman, L Holden, KA Read, JM Dondelinger, F Carson, G Merson, L Lee, J Plotkin, D Sigfrid, L Halpin, S Jackson, C Gamble, C Horby, PW Nguyen-Van-Tam, JS Ho, A Russell, CD Dunning, J Openshaw, PJM Baillie, JK Semple, MG |
Item Type: | Journal Article |
Abstract: | Objective To characterise the clinical features of patients admitted to hospital with coronavirus disease 2019 (covid-19) in the United Kingdom during the growth phase of the first wave of this outbreak who were enrolled in the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) World Health Organization (WHO) Clinical Characterisation Protocol UK (CCP-UK) study, and to explore risk factors associated with mortality in hospital.Design Prospective observational cohort study with rapid data gathering and near real time analysis.Setting 208 acute care hospitals in England, Wales, and Scotland between 6 February and 19 April 2020. A case report form developed by ISARIC and WHO was used to collect clinical data. A minimal follow-up time of two weeks (to 3 May 2020) allowed most patients to complete their hospital admission.Participants 20 133 hospital inpatients with covid-19.Main outcome measures Admission to critical care (high dependency unit or intensive care unit) and mortality in hospital.Results The median age of patients admitted to hospital with covid-19, or with a diagnosis of covid-19 made in hospital, was 73 years (interquartile range 58-82, range 0-104). More men were admitted than women (men 60%, n=12 068; women 40%, n=8065). The median duration of symptoms before admission was 4 days (interquartile range 1-8). The commonest comorbidities were chronic cardiac disease (31%, 5469/17 702), uncomplicated diabetes (21%, 3650/17 599), non-asthmatic chronic pulmonary disease (18%, 3128/17 634), and chronic kidney disease (16%, 2830/17 506); 23% (4161/18 525) had no reported major comorbidity. Overall, 41% (8199/20 133) of patients were discharged alive, 26% (5165/20 133) died, and 34% (6769/20 133) continued to receive care at the reporting date. 17% (3001/18 183) required admission to high dependency or intensive care units; of these, 28% (826/3001) were discharged alive, 32% (958/3001) died, and 41% (1217/3001) continued to receive care at the reporting date. Of those receiving mechanical ventilation, 17% (276/1658) were discharged alive, 37% (618/1658) died, and 46% (764/1658) remained in hospital. Increasing age, male sex, and comorbidities including chronic cardiac disease, non-asthmatic chronic pulmonary disease, chronic kidney disease, liver disease and obesity were associated with higher mortality in hospital.Conclusions ISARIC WHO CCP-UK is a large prospective cohort study of patients in hospital with covid-19. The study continues to enrol at the time of this report. In study participants, mortality was high, independent risk factors were increasing age, male sex, and chronic comorbidity, including obesity. This study has shown the importance of pandemic preparedness and the need to maintain readiness to launch research studies in response to outbreaks.Study registration ISRCTN66726260. |
Issue Date: | 22-May-2020 |
Date of Acceptance: | 15-May-2020 |
URI: | http://hdl.handle.net/10044/1/79468 |
DOI: | 10.1136/bmj.m1985 |
ISSN: | 1759-2151 |
Publisher: | BMJ Publishing Group Ltd |
Start Page: | 1 |
End Page: | 12 |
Journal / Book Title: | BMJ |
Volume: | 369 |
Issue: | 4 |
Copyright Statement: | © 2020 The Author(s). This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/. |
Sponsor/Funder: | Wellcome Trust Wellcome Trust Medical Research Council (MRC) Medical Research Council (MRC) Medical Research Council (MRC) Imperial College Healthcare NHS Trust- BRC Funding GlaxoSmithKline Services Unlimited Commission of the European Communities National Institute for Health Research National Institute for Health Research UKRI MRC COVID-19 Rapid Response Call |
Funder's Grant Number: | 090382/Z/09/Z 090382/Z/09/Z MR/R502121/1 MR/R005982/1 MR/R005982/1 RDA02 PO 3000941762 806776 NIHR201385 NIHR200927 MC_PC19025 |
Keywords: | Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine RISK-FACTORS ILLNESS Adolescent Adult Age Factors Aged Aged, 80 and over Betacoronavirus COVID-19 Child Child, Preschool Comorbidity Coronavirus Infections Critical Care Female Hospitalization Humans Infant Infant, Newborn Male Middle Aged Pandemics Pneumonia, Viral Prospective Studies Respiration, Artificial Risk Factors SARS-CoV-2 Sex Factors United Kingdom Young Adult ISARIC4C investigators Humans Pneumonia, Viral Coronavirus Infections Respiration, Artificial Critical Care Hospitalization Risk Factors Prospective Studies Age Factors Comorbidity Sex Factors Adolescent Adult Aged Aged, 80 and over Middle Aged Child Child, Preschool Infant Infant, Newborn Female Male Young Adult Pandemics United Kingdom Betacoronavirus COVID-19 SARS-CoV-2 |
Notes: | elocation-id: m1985 |
Publication Status: | Published |
Online Publication Date: | 2020-05-22 |
Appears in Collections: | National Heart and Lung Institute Faculty of Medicine Imperial College London COVID-19 |